The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A 5-gene signature based on TLR4 signaling as predictive of risk of distant relapse in breast cancer treated with taxane-anthracycline neoadjuvant chemotherapy.
Joseph A. Pinto
No relevant relationships to disclose
Claudio J Flores
No relevant relationships to disclose
Priscila I. Valdiviezo
No relevant relationships to disclose
Alfredo Aguilar
No relevant relationships to disclose
Juan F. Suazo
No relevant relationships to disclose
Mayer Zaharia
No relevant relationships to disclose
Richard Dyer
No relevant relationships to disclose
Carlos Vigil
No relevant relationships to disclose
Carlos S. Vallejos
No relevant relationships to disclose
Henry Gomez
No relevant relationships to disclose